Wireless Powered Closed Loop Neuromodulation
INOPASE
EXPLORING A NEW WAY OF TREATING CHRONIC NEUROLOGICAL DISEASES
THROUGH PERSONALIZED CLOSED-LOOP NEUROMODULATION
INOPASE empowers and supports people with chronic neurological diseases
to improve their quality of life
Nerve
Stimulation
Nerve
Sensing
Automatic
Adjustment
Neurons
Device
OUR CLOSED-LOOP NEUROMODULATION
Closed-loop neuromodulation is the key to restoring lost function by inducing neuroplasticity in the brain.
Our closed-loop neuromodulation has advanced algorithm to detect symptoms and provide dynamic stimulation therapy.
This innovative technology enables personalized treatment based on biological sensing, unlocking the full potential of your mind and body.
PROJECTS
An integrated solution that promises to revolutionize the way we diagnose and treat challenging diseases.
Closed-Loop
Sacral Neuromodulation
Imagine a breakthrough solution that could ease the burden on those struggling with overactive bladder, while increasing the chances of achieving long-awaited relief.
With the latest advancements in sensing and stimulation technology, we can now offer a path to overactive bladder remission that is both effective and compassionate, helping patients take back control of their lives and achieve the freedom they deserve.
Closed-Loop
Brain Neuromodulation
Imagine a groundbreaking device that has the potential to alleviate the challenges faced by individuals with drug-resistant epilepsy, opening up new possibilities and solutions for them.
By combining cutting-edge sensing and stimulation technology, flexible electrode innovations, and insights of leading clinical experts, we are developing an integrated solution that promises to revolutionize the way we diagnose and treat this challenging condition.
MEMBERS
MUNEMASA SUGIMOTO
Founder & CEO
• 10 years+ business experiences in healthcare industry (Novartis, CDI Medical)
• Project Assistant Professor at the University of Tokyo Hospital
• Japan BIODESIGN Innovation Fellow
• CPA experience (KPMG AZSA LLC.)
• MBA at Washington University in St. Louis, US
WANG YEN PO
Founder & CTO
• 8 years+ experiences in wireless power and closed-loop stimulation development
• Ph.D student in Human Engineer at the University of Tokyo
• Japan BIODESIGN Innovation Fellow
• Fellowship at Innovation for Intelligent World
• BE Health Ventures, Japan PJ Lead
KUMI SAKURAI
CMO
• 15 years+ business and marketing experiences in medical device industry (Medtronic, Abbott, Danaher Corporation)
• Premo Partners, Inc., CEO
• Research Fellow at Keio univ. hospital
• MBA at Kanazawa Institute of Technology, Japan. Master at Waseda University, Japan
PARTNERS
Japan agency for medical research
and development
Tokyo Metropolitan
Small & Medium Entreprise Support Center
Japan External
Trade Organization
B.E.
Accelerator
CP Medical Consulting
COFORCE
LINK Medical
Tohoku University Hospital
Industrial Technology Research Institute
Tokyo Institute of Technology
The University of Tokyo
Yokohama City University
Fukushima Medical University
Dokkyo Medical University
Nagano Prefectural
Shinshu Medical Center
Marien Hospital
HerneUniversitätsklinikum der Ruhr-Universität Bochum
Fukushima Medical University
Dokkyo Medical University
Nagano Prefectural
Shinshu Medical Center
Marien Hospital
HerneUniversitätsklinikum der Ruhr-Universität Bochum
Fukushima Medical University
Dokkyo Medical University
Nagano Prefectural
Shinshu Medical Center
Marien Hospital
HerneUniversitätsklinikum der Ruhr-Universität Bochum
Lifetime Ventures
Incubate Fund
NEWS
2023/09/19
INOPASE is joining JHVS Venture Awards 2023 (Pacifico Yokohama) event on October 12th.
2023/06/12
INOPASE joins the Neuro Medtech development group at Tokyo Institute of Technology.
2023/06/12
INOPASE obtained funding from Japan Agency for Medical Research and Development (AMED).
2023/06/12
INOPASE is joining ICT SPRING 2023 event in Luxenbourg on June 29th and 30th.
2023/06/12
INOPASE is joining Bits & Pretzels healthtech 2023 event in Munich, Germany on June 20th and 21st.
2023/06/07
INOPASE is joining prestigious STARTUP CREASPHERE event in Munich, Germany on June 19th.
2023/02/28
INOPASE participated in the 3rd Japan Biodesign Conference (as speaker and booth exhibitor)
2022/09/28
INOPASE was selected for the 2022 Foreign Patent Application Fee Subsidy Program
2022/09/07
INOPASE will participate in Japan Analytical & Scientific Instruments Show, JASIS 2022
2022/06/08
INOPASE obtained funding from Japan Agency for Medical Research and Development (AMED)
2021/06/24
INOPASE obtained funding from Japan Agency for Medical Research and Development (AMED)